Eribulina Advanz Pharma

Eribulin Mesylate is a chemotherapy drug used to treat certain types of cancer. It works by slowing or stopping cancer cell growth, often used in advanced breast cancer treatment.

Eribulin Mesylate is primarily used in the treatment of metastatic breast cancer. It may also be used for other types of cancer as determined by a healthcare provider. The drug is administered intravenously and targets cancer cells to inhibit their growth and spread.

Common effects of Eribulin Mesylate may include fatigue, nausea, and hair loss. Some individuals may experience more severe side effects such as low blood cell counts or nerve damage. Always consult a healthcare provider for personalized advice.

Eribulin Mesylate should be handled with care and administered under medical supervision. It is important to follow all safety guidelines provided by the healthcare provider. Pregnant women and individuals with certain medical conditions should discuss potential risks with their doctor.

Eribulin Mesylate may interact with other medications, including those that affect the liver or immune system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.